BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23179261)

  • 1. Follow-up of primary Sjogren's syndrome patients presenting positive anti-cyclic citrullinated peptides antibody.
    Ryu YS; Park SH; Lee J; Kwok SK; Ju JH; Kim HY; Jeon CH
    Rheumatol Int; 2013 Jun; 33(6):1443-6. PubMed ID: 23179261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevalence and significance of immunoglobulin G-anti-cyclic citrullinated peptide antibodies in primary Sjogren's syndrome patients].
    Liu Y; Wang YF; Wang KL; Lv FF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Jun; 46(3):478-82. PubMed ID: 24943033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-CCP and antikeratin antibodies in rheumatoid arthritis, primary Sjögren's syndrome, and Wegener's granulomatosis.
    Kamali S; Polat NG; Kasapoglu E; Gul A; Ocal L; Aral O; Konice M; Badur S; Inanc M
    Clin Rheumatol; 2005 Nov; 24(6):673-6. PubMed ID: 15926038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical significance of anti-cyclic citrullinated peptide antibody in primary Sjögren syndrome.
    Kim SM; Park E; Lee JH; Lee SH; Kim HR
    Rheumatol Int; 2012 Dec; 32(12):3963-7. PubMed ID: 22205381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren's syndrome.
    Gottenberg JE; Mignot S; Nicaise-Rolland P; Cohen-Solal J; Aucouturier F; Goetz J; Labarre C; Meyer O; Sibilia J; Mariette X
    Ann Rheum Dis; 2005 Jan; 64(1):114-7. PubMed ID: 15231509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-cyclic citrullinated peptide antibodies in primary Sjögren syndrome may be associated with non-erosive synovitis.
    Atzeni F; Sarzi-Puttini P; Lama N; Bonacci E; Bobbio-Pallavicini F; Montecucco C; Caporali R
    Arthritis Res Ther; 2008; 10(3):R51. PubMed ID: 18462485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of IgA class antibodies to cyclic citrullinated peptide (anti-CCP) in patients with primary Sjögren's syndrome, and its association to clinical manifestations.
    Haga HJ; Andersen DT; Peen E
    Clin Rheumatol; 2011 Mar; 30(3):369-72. PubMed ID: 21234630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing hand and wrist ultrasound pattern in primary Sjögren's syndrome: a case-control study.
    Guedes LKN; Leon EP; Bocate TS; Bonfigliolli KR; Lourenço SV; Bonfa E; Pasoto SG
    Clin Rheumatol; 2020 Jun; 39(6):1907-1918. PubMed ID: 32072351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of the subset of Sjogren's syndrome with articular manifestations by anticyclic citrullinated peptide antibodies.
    Iwamoto N; Kawakami A; Tamai M; Fujikawa K; Arima K; Aramaki T; Kawashiri S; Ichinose K; Kamachi M; Nakamura H; Origuchi T; Ida H; Eguchi K
    J Rheumatol; 2009 Jan; 36(1):113-5. PubMed ID: 19132785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic utilities of anti-agalactosyl IgG antibodies, anti-cyclic citrullinated peptide antibodies, and rheumatoid factors in rheumatoid arthritis.
    Ryu HJ; Takeuchi F; Kuwata S; Kim YJ; Lee EY; Lee EB; Song YW
    Rheumatol Int; 2011 Mar; 31(3):315-9. PubMed ID: 20012964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-cyclic citrullinated peptide antibodies in hepatitis C virus associated rheumatological manifestations and Sjogren's syndrome.
    Sène D; Ghillani-Dalbin P; Limal N; Thibault V; van Boekel T; Piette JC; Cacoub P
    Ann Rheum Dis; 2006 Mar; 65(3):394-7. PubMed ID: 16474032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticyclic citrullinated peptide antibodies in rheumatoid and nonrheumatoid rheumatic disorders: experience with 1162 patients.
    Payet J; Goulvestre C; Bialé L; Avouac J; Wipff J; Job-Deslandre C; Batteux F; Dougados M; Kahan A; Allanore Y
    J Rheumatol; 2014 Dec; 41(12):2395-402. PubMed ID: 25274898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in Sjögren's syndrome.
    Barcelos F; Abreu I; Patto JV; Trindade H; Teixeira A
    Acta Reumatol Port; 2009; 34(4):608-12. PubMed ID: 20087267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-cyclic citrullinated peptide, rheumatoid factor, and ocular symptoms typical of rheumatoid arthritis.
    Itty S; Pulido JS; Bakri SJ; Baratz KH; Matteson EL; Hodge DO
    Trans Am Ophthalmol Soc; 2008; 106():75-81; discussion 81-3. PubMed ID: 19277223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of novel autoantibody isotypes against citrullinated-inter-alpha-trypsin inhibitor heavy chain 3 (ITIH3)(542-556) peptide in serum from Taiwanese females with rheumatoid arthritis, primary Sjögren's syndrome and secondary Sjögren's syndrome in rheumatoid arthritis.
    Liao CC; Chou PL; Cheng CW; Chang YS; Chi WM; Tsai KL; Chen WJ; Kung TS; Tai CC; Lee KW; Chen YC; Lin CY
    J Proteomics; 2016 Jun; 141():1-11. PubMed ID: 27072115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence and diagnostic performance of anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: the predictive and discriminative ability of serum antibody level in recognizing rheumatoid arthritis.
    Heidari B; Firouzjahi A; Heidari P; Hajian K
    Ann Saudi Med; 2009; 29(6):467-70. PubMed ID: 19847085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performance of anti-cyclic citrullinated peptide and rheumatoid factor in patients with rheumatoid arthritis.
    Chang PY; Yang CT; Cheng CH; Yu KH
    Int J Rheum Dis; 2016 Sep; 19(9):880-6. PubMed ID: 25940989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyarthritis in primary Sjögren's syndrome represents a distinct subset with less pronounced B cell proliferation a Dutch cohort with long-term follow-up.
    ter Borg EJ; Kelder JC
    Clin Rheumatol; 2016 Mar; 35(3):649-55. PubMed ID: 26791875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Predictive values of anti-cyclic citrullinated peptide antibody, antikeratin antibody and rheumatoid factor in diagnosing articular erosions in patients with rheumatoid arthritis].
    Xie QB; Yin G
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):508-12. PubMed ID: 19627016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-cyclic citrullinated peptide antibody in systemic sclerosis.
    Morita Y; Muro Y; Sugiura K; Tomita Y
    Clin Exp Rheumatol; 2008; 26(4):542-7. PubMed ID: 18799082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.